ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
EXASOL AG

EXASOL AG (EXL)

2.74
0.03
(1.11%)
Closed January 29 3:00PM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.74
Bid
2.68
Ask
2.79
Volume
12,172
2.63 Day's Range 2.80
1.595 52 Week Range 3.495
Market Cap
Previous Close
2.71
Open
2.76
Last Trade
300
@
2.78
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
24,752
Shares Outstanding
26,882,757
Dividend Yield
-
PE Ratio
-8.87
Earnings Per Share (EPS)
-0.31
Revenue
38.1M
Net Profit
-8.21M

About EXASOL AG

Sector
Computer Programming Service
Industry
Computer Programming Service
Website
Headquarters
Nuremberg, Deu
Founded
-
EXASOL AG is listed in the Computer Programming Service sector of the Tradegate (DE) with ticker EXL. The last closing price for EXASOL was 2.71 €. Over the last year, EXASOL shares have traded in a share price range of 1.595 € to 3.495 €.

EXASOL currently has 26,882,757 shares outstanding. The market capitalization of EXASOL is 72.85 € million. EXASOL has a price to earnings ratio (PE ratio) of -8.87.

EXL Latest News

Exel aquires Pharma Logistics Group

EXEL ACQUIRES PHARMA LOGISTICS GROUP - A LEADING EUROPEAN HEALTHCARE LOGISTICS BUSINESS (London, UK - 15 January 2004) - Exel, the global leader in supply chain management, has announced today...

Notice of Results

DATE OF PRELIMINARY RESULTS (London, UK, 9 January 2004) Exel plc, the global leader in supply chain solutions, today confirmed that the company would be announcing its full year results for the...

Director Shareholding

SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Exel plc 2) Name of director Ian Richard Smith 3) Please state whether notification indicates that...

Exel Investor Day

RNS Number:7071S Exel PLC 02 December 2003 EXEL HOSTS INVESTOR CONFERENCE Confirms expectations for another year of solid progress (London, UK - 2 December 2003) Exel, the global leader...

Exel company statement

RNS Number:5008S Exel PLC 26 November 2003 EXEL ANNOUNCES AN EXCEPTIONAL GAIN Initial public offering of Sirva Inc will realise around $50m in cash in 2003 with significant potential...

Acquisition

RNS Number:8504R Exel PLC 10 November 2003 EXEL ACQUIRES LEADING ITALIAN LOGISTICS CAPABILITY (London UK, 10 November 2003) - Exel, a world leader in supply chain management...

Exel confirms good third quarter trading

EXEL CONFIRMS GOOD THIRD QUARTER TRADING (London, UK, 28 October, 2003) Exel plc, the global leader in supply chain solutions, today confirmed that trading through the third quarter had been good...

EXEL WINS MOD CONTRACT

RNS Number:1125R Exel PLC 21 October 2003 EXEL WINS #42 MILLION MINISTRY OF DEFENCE CONTRACT (London, UK - 21 October 2003) Exel, the global leader in supply chain management, has won a...

Holding(s) in Company

SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Exel plc 2) Name of shareholder having a major interest Morley Fund Management Limited (a subsidiary of Aviva plc) 3...

Director Shareholding

SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) Name of company Exel plc 2) Name of director Nigel Mervyn Sutherland Rich 3) Please state whether notification...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.13-4.529616724742.872.952.63181042.75463733DE
40.3514.64435146442.393.222.2599999343722.78853755DE
120.76538.73417721521.9753.221.925247522.52356843DE
260.460000120.17544386732.27999993.221.595200942.29064197DE
52-0.565-17.09531013623.3053.4951.595188212.44729688DE
156-3.56-56.50793650796.37.751.595328763.95987379DE
260-11.26-80.42857142861429.481.595431199.15618244DE

EXL - Frequently Asked Questions (FAQ)

What is the current EXASOL share price?
The current share price of EXASOL is 2.74 €
How many EXASOL shares are in issue?
EXASOL has 26,882,757 shares in issue
What is the market cap of EXASOL?
The market capitalisation of EXASOL is EUR 72.85M
What is the 1 year trading range for EXASOL share price?
EXASOL has traded in the range of 1.595 € to 3.495 € during the past year
What is the PE ratio of EXASOL?
The price to earnings ratio of EXASOL is -8.87
What is the cash to sales ratio of EXASOL?
The cash to sales ratio of EXASOL is 1.91
What is the reporting currency for EXASOL?
EXASOL reports financial results in EUR
What is the latest annual turnover for EXASOL?
The latest annual turnover of EXASOL is EUR 38.1M
What is the latest annual profit for EXASOL?
The latest annual profit of EXASOL is EUR -8.21M
What is the registered address of EXASOL?
The registered address for EXASOL is NEUMEYERSTR. 22 - 26, NUREMBERG, 90411
What is the EXASOL website address?
The website address for EXASOL is www.exasol.com
Which industry sector does EXASOL operate in?
EXASOL operates in the COMPUTER PROGRAMMING SERVICE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
C1VMvise AG
0.735 €
(121.39%)
155.89k
48QX4 Pharmaceuticals Inc
0.698 €
(46.76%)
12.05k
1ZY0Medaro Mining Corp
0.156 €
(43.12%)
44.6k
O0KBayridge Resources Corp
0.06 €
(42.86%)
133.5k
1RR1Rokmaster Resources Corp
0.017 €
(41.67%)
20k
45AAlchemy Resource Ltd
0.003 €
(-33.33%)
5.16k
W1HOnco Innovations Limited
1.09 €
(-29.22%)
706.62k
LL3PanGenomic Health Inc
0.15 €
(-28.50%)
24.79k
PA8Paion AG
0.016 €
(-25.93%)
8.09k
EJ7Energy Resources of Australia
0.0015 €
(-25.00%)
10k
3CPXiaomi Corporation
4.98 €
(1.71%)
3.23M
D7GNel ASA
0.1939 €
(-2.86%)
2.57M
52D0WonderFi Technologies Inc
0.196 €
(-2.73%)
1.92M
NVDNVIDIA Corp
118.64 €
(-3.80%)
1.57M
LHADeutsche Lufthansa AG
6.188 €
(-2.86%)
1.31M

Discussion

View Full Feed
Backstabbed Backstabbed 6 minutes ago
25,000 shares x $0.20 = $5,000 USD
ZHUD
newmedman newmedman 6 minutes ago
Hold on to the truth…
A recording from Jim Acosta's Substack live video
JIM ACOSTA
JAN 28, 2025
It was early March in 2007 when I received a phone call in the middle of the night. CNN’s bureau chief in New York at the time, Edith Chapin, called to deploy me to the Bronx o
MartinLutherKing MartinLutherKing 6 minutes ago
https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors?
RNAZ
valuemind valuemind 6 minutes ago
2025-2027 will be TSLA years!
TSLA
jondoeuk jondoeuk 7 minutes ago
The PR is an utter mess! The ORR across subgroups is higher, but the (m)PFS isn't that great.
FATE
MartinLutherKing MartinLutherKing 7 minutes ago
FDA Approves TransCode's Phase 1/2 Trial of TTX-MC138 for Advanced Solid Tumors
18 April 2024
3 min read
TransCode Therapeutics, Inc., a specialist in RNA oncology, has revealed that the U.S. Food and Drug Administration has finished reviewing their Investigational New Drug appl
RNAZ
Backstabbed Backstabbed 8 minutes ago
50,000 shares x $0.20 = $10,000 USD
ZHUD
Backstabbed Backstabbed 9 minutes ago
100,000 shares x $0.20 = $20,000 USD
ZHUD
Backstabbed Backstabbed 9 minutes ago
250,000 shares x $0.20 = $50,000 USD
ZHUD
ChartTRACKER ChartTRACKER 9 minutes ago
$ADTX: Lay off the Kool-aid buddy!
250:1 😂 ! [You go that wrong too! You post is showing as a F/S]!!

A Company needs to maintain > 500k Shs to be listed on NASDAQ after a R/S.
ADTX
Backstabbed Backstabbed 10 minutes ago
500,000 shares x $0.20 = $100,000
ZHUD
Techroemancer Techroemancer 10 minutes ago
Hopefully the momentum of the volume will continue to uptick. With the current O/S, we need some big volume days to get us out of the trips land. The financials and performance are phenomenal and once we can gain some traction/momentum, this should be easy to launch. Just need the interest/volume an
ASII
MartinLutherKing MartinLutherKing 10 minutes ago
TTX-MC-138 targets miR-10b and has potential applications in the treatment of various cancers and diseases affecting different body systems. The drug is currently in Phase 1/2 of development and has been designated as an orphan drug, indicating its potential to address unmet medical needs in rare di
RNAZ
zab zab 10 minutes ago
Trump's pandemic killed 1.3 million Americans,  you must be so happy with his choice to downplay it.
Backstabbed Backstabbed 10 minutes ago
1,000,000 shares x $0.20 = $200,000 USD
ZHUD
Backstabbed Backstabbed 10 minutes ago
Cohen said $0.20 by May 2025! $ZHUD
ZHUD
stealofadeal stealofadeal 11 minutes ago
$KRTL Another good day today. Thin share structure and going to move fast.
KRTL
bb8675309 bb8675309 11 minutes ago
Hey Bourbon. Good to hear from you. Yes, it would be great if they brought back the uptick rule. Might help. Maybe that's the way market shorting was once done and is intended to work but today shorts are destroying good companies. I don't believe the retail investor has SEC protection in the market
AVXL
Whalatane Whalatane 11 minutes ago
Ha ha ...hope not . Usually analysts give 1 yr targets
Co will be hosting a commercialization day this Qt I think ...to show they are ready to launch as soon as approved
Kiwi
UNCY
Ex-brokerBry Ex-brokerBry 11 minutes ago
Ok Georgie18,do you have any idea who that seller is.?When will this end.Stocks have a tendency to go down slowly and then rise guickly.My Morgan Stanley has a final price after that 1 milly buy at the end at .0457....I've been burned with these kind of stocks.If it drops below .03 I'm buying more.Y
UMAV
jondoeuk jondoeuk 11 minutes ago
We won't know until it is tested, but from this: 'We found activated CD19 CAR.ADR T cells have lower levels of detectable 4-1BB on their surface compared to CD19 CAR T cells, suggesting partial downregulation or masking of 4-1BB upon ADR expression (Supplementary Fig. 9a). Indeed, expression of a tr
FATE
nowwhat2 nowwhat2 12 minutes ago
What a performance eh ?.......How's about THAT ?

https://investorshub.advfn.com/uimage/uploads/2025/1/29/bghbxBTC_!_29_15d_930am_fomc_deep_import.jpg


https://investorshub.advfn.com/uimage/uploads/2025/1/29/ipgjvbtc_!_29_15d_2pm_FOMC_update_100k.jpg
valuemind valuemind 12 minutes ago
NXT outperformed FSLR nearly 50% in the past 3 months. Stock selection is apparently more important than industry selection.
FSLR NXT

Your Recent History

Delayed Upgrade Clock